Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS in the Highland
1 other identifier
observational
100
1 country
1
Brief Summary
The study is conducted in the affiliated hospital of Qinghai University .Patients in the department of Critical Care Medicine and Emergency Intensive Care Unit will be eligible for inclusion if they meet the Berlin criteria.Two researchers assess pulmonary artery pressure and right heart function of patients who are enrolled.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2021
CompletedFirst Submitted
Initial submission to the registry
December 20, 2021
CompletedFirst Posted
Study publicly available on registry
December 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedDecember 22, 2021
November 1, 2021
3 months
December 20, 2021
December 21, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence of Pulmonary Hypertension Secondary to ARDS in the Highland
20/11/2021-20/12/2022
ICU mortality ICU mortality
Mortality during treatment in ICU
20/11/2021-20/12/2022
28-days mortality rate
Mortality at 28 days of hospitalization
20/11/2021-20/12/2022
Secondary Outcomes (2)
Ventilator time
20/11/2021-20/12/2022
Hospital length of stay
20/11/2021-20/12/2022
Other Outcomes (1)
Right cardiac functionof Pulmonary Hypertension Secondary to ARDS in the Highland
20/11/2021-20/12/2022
Interventions
Pulmonary artery pressure and right heart function will be assessed using Doppler ultrasound
Eligibility Criteria
The study is conducted in the affiliated hospital of Qinghai University .Patients in the department of Critical Care Medicine and Emergency Intensive Care Unit will be eligible for inclusion if they meet the Berlin criteria.Two researchers assess pulmonary artery pressure and right heart function of patients who are enrolled.
You may qualify if:
- to 80 years of age Meet the diagnostic criteria Receive invasive mechanical ventilation within 48 hours
You may not qualify if:
- Patients with those disease will be excluded ： chronic obstructive pulmonary disease Pulmonary embolism Chronic heart failure Idiopathic pulmonary fibrosis Pulmonary hypertension Pregnant women will be excluded too.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Southeast University, Chinalead
- Qinghai Universitycollaborator
Study Sites (1)
Affiliated Hospital of QingHai University
Xining, Qinghai, China
Related Publications (1)
Zhu P, Zhu J, Tong S, She X, Qi Z, Xu Q, Shi Z, Si L, Hou M, Gan G, Pan C. Clinical characteristics of patients with a risk of pulmonary artery hypertension secondary to ARDS in a high-altitude area. BMJ Open Respir Res. 2023 Jul;10(1):e001475. doi: 10.1136/bmjresp-2022-001475.
PMID: 37524522DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chun Pan, MD
Qinghai University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 28 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chun Pan
Study Record Dates
First Submitted
December 20, 2021
First Posted
December 22, 2021
Study Start
November 25, 2021
Primary Completion
March 1, 2022
Study Completion
December 1, 2022
Last Updated
December 22, 2021
Record last verified: 2021-11